annual FCF:
-$6.73M+$57.99M(+89.60%)Summary
- As of today (August 16, 2025), TXG annual free cash flow is -$6.73 million, with the most recent change of +$57.99 million (+89.60%) on December 31, 2024.
- During the last 3 years, TXG annual FCF has risen by +$115.92 million (+94.51%).
- TXG annual FCF is now at all-time high.
Performance
TXG Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
$16.13M-$16.33M(-50.31%)Summary
- As of today (August 16, 2025), TXG quarterly free cash flow is $16.13 million, with the most recent change of -$16.33 million (-50.31%) on June 30, 2025.
- Over the past year, TXG quarterly FCF has increased by +$12.51 million (+345.83%).
- TXG quarterly FCF is now -50.31% below its all-time high of $32.46 million, reached on March 31, 2025.
Performance
TXG quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
$56.88M+$12.51M(+28.20%)Summary
- As of today (August 16, 2025), TXG TTM free cash flow is $56.88 million, with the most recent change of +$12.51 million (+28.20%) on June 30, 2025.
- Over the past year, TXG TTM FCF has increased by +$90.33 million (+270.04%).
- TXG TTM FCF is now at all-time high.
Performance
TXG TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
TXG Free cash flow Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +89.6% | +345.8% | +270.0% |
3 y3 years | +94.5% | +136.5% | +135.2% |
5 y5 years | +17.3% | +144.5% | +223.8% |
TXG Free cash flow Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +95.9% | -50.3% | +135.0% | at high | +134.4% |
5 y | 5-year | at high | +97.4% | -50.3% | +110.6% | at high | +119.7% |
alltime | all time | at high | +97.4% | -50.3% | +110.6% | at high | +119.7% |
TXG Free cash flow History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | $16.13M(-50.3%) | $56.88M(+28.2%) |
Mar 2025 | - | $32.46M(-443.0%) | $44.36M(-759.3%) |
Dec 2024 | -$6.73M(-89.6%) | -$9.46M(-153.3%) | -$6.73M(-126.9%) |
Sep 2024 | - | $17.75M(+390.7%) | $25.04M(-174.9%) |
Jun 2024 | - | $3.62M(-119.4%) | -$33.45M(-54.8%) |
Mar 2024 | - | -$18.64M(-183.5%) | -$73.95M(+14.3%) |
Dec 2023 | -$64.72M(-60.8%) | $22.31M(-154.8%) | -$64.72M(-42.7%) |
Sep 2023 | - | -$40.74M(+10.5%) | -$113.04M(-4.6%) |
Jun 2023 | - | -$36.88M(+292.1%) | -$118.44M(-5.8%) |
Mar 2023 | - | -$9.41M(-63.8%) | -$125.74M(-23.9%) |
Dec 2022 | -$165.27M(+34.7%) | -$26.01M(-43.6%) | -$165.27M(+2.6%) |
Sep 2022 | - | -$46.14M(+4.4%) | -$161.07M(-0.2%) |
Jun 2022 | - | -$44.18M(-9.7%) | -$161.38M(+25.4%) |
Mar 2022 | - | -$48.94M(+124.4%) | -$128.64M(+4.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2021 | -$122.65M(-52.1%) | -$21.81M(-53.0%) | -$122.65M(-51.6%) |
Sep 2021 | - | -$46.44M(+305.7%) | -$253.28M(-4.0%) |
Jun 2021 | - | -$11.45M(-73.3%) | -$263.77M(-8.6%) |
Mar 2021 | - | -$42.95M(-71.8%) | -$288.58M(+12.6%) |
Dec 2020 | -$256.29M(+3048.6%) | -$152.44M(+167.7%) | -$256.29M(+147.1%) |
Sep 2020 | - | -$56.94M(+57.0%) | -$103.73M(+125.8%) |
Jun 2020 | - | -$36.26M(+240.3%) | -$45.95M(+145.1%) |
Mar 2020 | - | -$10.65M(-9053.8%) | -$18.75M(+130.3%) |
Dec 2019 | -$8.14M(-90.2%) | $119.00K(-86.0%) | -$8.14M(-1.4%) |
Sep 2019 | - | $848.00K(-109.4%) | -$8.26M(-9.3%) |
Jun 2019 | - | -$9.06M(>+9900.0%) | -$9.11M(>+9900.0%) |
Mar 2019 | - | -$49.00K | -$49.00K |
Dec 2018 | -$83.12M(+475.0%) | - | - |
Dec 2017 | -$14.46M | - | - |
FAQ
- What is 10x Genomics, Inc. annual free cash flow?
- What is the all time high annual FCF for 10x Genomics, Inc.?
- What is 10x Genomics, Inc. annual FCF year-on-year change?
- What is 10x Genomics, Inc. quarterly free cash flow?
- What is the all time high quarterly FCF for 10x Genomics, Inc.?
- What is 10x Genomics, Inc. quarterly FCF year-on-year change?
- What is 10x Genomics, Inc. TTM free cash flow?
- What is the all time high TTM FCF for 10x Genomics, Inc.?
- What is 10x Genomics, Inc. TTM FCF year-on-year change?
What is 10x Genomics, Inc. annual free cash flow?
The current annual FCF of TXG is -$6.73M
What is the all time high annual FCF for 10x Genomics, Inc.?
10x Genomics, Inc. all-time high annual free cash flow is -$6.73M
What is 10x Genomics, Inc. annual FCF year-on-year change?
Over the past year, TXG annual free cash flow has changed by +$57.99M (+89.60%)
What is 10x Genomics, Inc. quarterly free cash flow?
The current quarterly FCF of TXG is $16.13M
What is the all time high quarterly FCF for 10x Genomics, Inc.?
10x Genomics, Inc. all-time high quarterly free cash flow is $32.46M
What is 10x Genomics, Inc. quarterly FCF year-on-year change?
Over the past year, TXG quarterly free cash flow has changed by +$12.51M (+345.83%)
What is 10x Genomics, Inc. TTM free cash flow?
The current TTM FCF of TXG is $56.88M
What is the all time high TTM FCF for 10x Genomics, Inc.?
10x Genomics, Inc. all-time high TTM free cash flow is $56.88M
What is 10x Genomics, Inc. TTM FCF year-on-year change?
Over the past year, TXG TTM free cash flow has changed by +$90.33M (+270.04%)